SCHEMBL4364932

SCHEMBL4364932

CCOC(=O)C(=N)CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28668080 0.85 ALDH1A1 (0.46)
SCHEMBL9622001 0.82
SCHEMBL23542529 0.82
SCHEMBL17219825 0.80 HCAR2 (0.39)
Hydrochloric Acid SCHEMBL28896364 0.80 ALDH1A1 (0.42)
SCHEMBL10263392 0.80
SCHEMBL27708839 0.80 ALDH1A1 (0.42)
SCHEMBL8581911 0.78 GAA (0.61)
SCHEMBL5113870 0.78 ALDH1A1 (0.40)
SCHEMBL23136227 0.78 ALDH1A1 (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117486818-A N-phenyl thiotriazinone derivative and preparation method and application thereof 贵州大学 2024-02-02 CN claimed
CN-117486818-A N-phenyl thiotriazinone derivative and preparation method and application thereof 贵州大学 2024-02-02 CN disclosed
US-20230054928-A1 METHOD FOR PREPARING CARBONYL SULFONE SOOCHOW UNIVERSITY (CN) 2023-02-23 US disclosed
CN-110475474-B Compounds and methods of use 西格纳姆生物科学公司 2022-11-04 CN disclosed
US-10934531-B2 Method for enantioselective carbene C—H insertion using an iron-containing protein catalyst CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2021-03-02 US disclosed
US-20190276805-A1 METHOD FOR ENANTIOSELECTIVE CARBENE C-H INSERTION USING AN IRON-CONTAINING PROTEIN CATALYST CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2019-09-12 US disclosed
WO-2019147865-A1 A METHOD FOR ENANTIOSELECTIVE CARBENE C-H INSERTION USING AN IRON-CONTAINING PROTEIN CATALYST CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2019-08-01 WO disclosed
CN-102858159-B Chemical compounds GLAXOSMITHKLINE LLC 2015-02-11 CN disclosed
CN-102633835-B Method for synthetizing N-( phosphonomethyl) iminodiacetic acid JIANGSU GOOD HARVEST-WEIEN AGROCHEMICAL CO., LTD. (CN) 2014-10-29 CN disclosed
CN-103998427-A Oxime ester photoinitiators BASF SE 2014-08-20 CN disclosed
WO-2009019173-A1 OXIME ESTER PHOTOINITIATORS BASF SE (CH) 2009-02-12 WO disclosed
US-7132437-B2 for example, methyl 4'-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl][1,1'-biphenyl]-2-carboxylate; for treatment of congestive heart failure G.D. SEARLE (US) 2006-11-07 US disclosed
US-20040220245-A1 for example, methyl 4'-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl][1,1'-biphenyl]-2-carboxylate; for treatment of congestive heart failure G.D. SEARLE & CO., 2004-11-04 US disclosed
US-20040121989-A1 such as methyl 4'-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl][1,1'-biphenyl]-2-carboxylate; for treatment of congestive heart failure G.D. SEARLE & CO. 2004-06-24 US disclosed
EP-0527851-B1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS SEARLE & CO (US) 1998-12-23 EP disclosed
US-5217985-A RENAL-SELECTIVE BIPHENYLALKYL 1H-SUBSTITUTED-1,2,4-TRIAZOLE ANGIOTENSIN II ANTAGONISTS FOR TREATMENT OF HYPERTENSION G. D. SEARLE & CO. (US) 1993-06-08 US disclosed
EP-0527851-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1993-02-24 EP disclosed
US-5098920-A Hypotensive agents and treatment of congestive heart failure G. D. SEARLE & CO. (US) 1992-03-24 US disclosed
WO-1992004335-A2 RENAL-SELECTIVE BIPHENYLALKYL 1H-SUBSTITUTED-1,2,4-TRIAZOLE ANGIOTENSIN II ANTAGONISTS FOR TREATMENT OF HYPERTENSION G.D. SEARLE & CO. (US) 1992-03-19 WO disclosed
WO-1991017148-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1991-11-14 WO disclosed